Because we are also aware of rare cases of CD associated with genotypes containing HLA-DQA1*05 in the Czech population, our latest national recommendation for HLA testing in CD from 2023 complies with the above-mentioned Australian paper. This evidence concerns the gene HLA-DQA1 and Cowden disease.